It references the study "Exenatide Versus Insulin Glargine: A Cost-Effectiveness Evaluation in Patients With Type 2 Diabetes in Switzerland," by M. Br盲ndle and colleagues, published in the August 2009 issue of "International Journal of Clinical Pharmacology and Therapeutics." The incremental cost-...
Cost-effectiveness of Insulin Glargine Versus Sitagliptin in Insulin-naïve Patients With Type 2 Diabetes Mellitus Stephen T. Brown, PhD 1 ; Daniel Grima Grima, MSc 1 ; and Luc Sauriol, MSc 2 1 Cornerstone Research Group Inc., Burlington, Ontario, Canada; and ...
AimsThe aim of this analysis was to evaluate the cost-effectiveness of insulin degludec (IDeg) versus insulin glargine (IGlar) in adults with type 2 diabetes mellitus (T2DM) who are considered appropriate for treatment with a basal insulin analogue, using a short-term economic model.MethodsMeta...
We examined the efficacy of conversion from NPH insulin to glargine in Japanese type I diabetic adults using basal/bolus therapy. Retrospective chart analysis was done for 41 patients 12 months after switching to insulin glargine therapy. Insulin glargine was well tolerated with less frequent unrecogni...
It is generally held that basal insulin substitution with continuous subcutaneous insulin infusion (CSII) provides less variable glucose levels than with long-acting insulin analogs, e.g., glargine, in patients with type 1 diabetes, although this has not been convincingly demonstrated by continuous ...
Cost effectivenessDiscrete event simulationIntensified conventional therapyInsulin glargineNPH insulinType 1 diabetesGermanyObjective:Basal insulin analogs are well established in the treatment of type 1 diabetes in Germany. However, little is known about their economic impact. The aim of this study for ...
A variety of economic analyses have confirmed the cost effectiveness of insulin glargine in type 1 and type 2 diabetes and in particular it was shown to be significantly superior to NPH insulin. Clinical value: Insulin glargine has established itself as a first-line choice in patients with type...
Toujeo® Max Solostar® is a 900 Unit pen with concentrated insulin, that can fit up to 3X more insulin in the same-size standard pen, which may mean fewer pens, injections, refills, and co-pays. See Important Safety Information.
By increasing population weight or glargine consumption, dulaglutide becomes cost-effective compared with glargine, which could identify a niche where dulaglutide is the best option.关键词: Colombia cost-effectiveness analysis diabetes dulaglutide insulin glargine liraglutide quality-adjusted life-years ...
Aims/hypothesisUsing the Echantillon Généraliste de Bénéficiaires: random 1/97 permanent sample of the French national healthcare insurance system database (EGB), we investigated whether, as previously suspected, the risk of cancer in insulin glargine (A21Gly,B31Arg,B32Arg human insulin) users...